Open AccessImproved survival in patients with ventricular assist device therapy: the University of Wisconsin experience
Author(s) -
Satoru Osaki,
Niloo M. Edwards,
Mauricio Velez,
Maryl R. Johnson,
Margaret Murray,
Jennifer A. Hoffmann,
Takushi Kohmoto
Publication year - 2008
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1016/j.ejcts.2008.04.023
Subject(s) - medicine , destination therapy , ventricular assist device , rehabilitation , demographics , cohort , incidence (geometry) , population , heart failure , emergency medicine , physical therapy , optics , physics , demography , sociology , environmental health
Ventricular assist devices (VADs) have been implanted since 1990 in our institution, becoming an increasingly common treatment for end-stage heart failure. Beginning in 1997, VAD patients were discharged home when feasible. In August 2003, a dedicated multidisciplinary VAD team (cardiac surgeons, cardiologists, VAD coordinators, nurses, rehabilitation specialists, nutrition experts, psychologists, pharmacists, social workers, and administrators) was created to optimize the management of VAD patients. The purpose of this study is to analyze the impact of these changes in care at our center over the last 17 years.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom